Karydas Daphne insider trades
Karydas Daphne has filed 14 Form 4s with the SEC that we hold, for Mineralys Therapeutics, Inc. (MLYS) (Director), COMPASS Pathways plc (CMPS) (Director) and LOGC (Director). Across all of them we count 0 purchases worth $0 and 5 sales worth $925.6K reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($925.6K). The largest single trade was a sale of 10,115 shares of Mineralys Therapeutics, Inc. worth $463.4K, dated 2025-11-13. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-07-05 and the latest 2026-09-17.
Mineralys Therapeutics, Inc. (MLYS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-11-13 | S, sale reported on Form 4 | 4,885 | $226.5K | 2025-11-13 |
| 2025-11-13 | S, sale reported on Form 4 | 10,115 | $463.4K | 2025-11-13 |
| 2026-03-31 | S, sale reported on Form 4 | 3,000 | $75.0K | 2026-04-02 |
| 2026-06-17 | S, sale reported on Form 4 | 3,000 | $75.0K | 2026-06-17 |
| 2026-09-15 | S, sale reported on Form 4 | 3,000 | $85.7K | 2026-09-17 |
COMPASS Pathways plc (CMPS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
LOGC (LOGC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1816952) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms